- Home
- SNDL vs NBP Comparison
SNDL vs NBP Comparison
Compare SNDL & NBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNDL | NBP |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | Canada | United States |
| Employees | N/A | 32 |
| Industry | Pharmaceuticals and Biotechnology | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.6M | 503.8M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SNDL | NBP |
|---|---|---|
| Price | $1.69 | $3.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 4.8M | 536.1K |
| Earning Date | 11-04-2025 | 02-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $683,170,243.00 | N/A |
| Revenue This Year | $5.48 | N/A |
| Revenue Next Year | $3.10 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4.43 | N/A |
| 52 Week Low | $1.15 | $0.60 |
| 52 Week High | $2.89 | $6.79 |
Technical Indicators
Market Signals| Indicator | SNDL | NBP |
|---|---|---|
| Relative Strength Index (RSI) | 43.63 | N/A |
| Support Level | $1.63 | N/A |
| Resistance Level | $2.34 | N/A |
| Average True Range (ATR) | 0.13 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 8.45 | 0.00 |
Price Performance
Historical ComparisonAbout SNDL SNDL Inc.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.
About NBP NovaBridge Biosciences American Depositary Shares
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab.